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Abstract
Current statistical inference problems in areas like astronomy, genomics, and marketing
routinely involve the simultaneous testing of thousands – even millions – of null hypotheses.
For high-dimensional multivariate distributions, these hypotheses may concern a wide range of
parameters, with complex and unknown dependence structures among variables. In analyzing
such hypothesis testing procedures, gains in efficiency and power can be achieved by performing
variable reduction on the set of hypotheses prior to testing. We present in this paper an approach
using data-adaptive multiple testing that serves exactly this purpose. This approach applies data
mining techniques to screen the full set of covariates on equally sized partitions of the whole
sample via cross-validation. This generalized screening procedure is used to create average
ranks for covariates, which are then used to generate a reduced (sub)set of hypotheses, from
which we compute test statistics that are subsequently subjected to standard multiple testing
corrections. The principal advantage of this methodology lies in its providing valid statistical
inference without the a priori specifying which hypotheses will be tested. Here, we present the
theoretical details of this approach, confirm its validity via simulation study, and exemplify its
use by applying it to the analysis of data on microRNA differential expression.
Key words: data mining, data-adaptive statistical target parameter, cross-validation, machine
learning, targeted maximum likelihood estimation.
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1 Introduction
Recently developed technologies enable high throughput screen of thousands (millions) of biological
molecules, which has resulted in filters that use multiple testing to highlight potentially informative
biomakers. For instance, consider microRNA, a new class of small, non-coding RNAs have been
the subject of intense study due to their central role in gene regulation (Wienholds et al., 2005).
In a process involving binding to messenger RNA (mRNA), miRNAs regulate gene expression at
the post-transcriptional level, thereby affecting the abundance of a wide range of proteins in diverse
biological processes. The resulting data consists of a large vector of microRNA expressions as well as
other characteristics and experimental conditions relevant to a particular biological sample. Before
looking at the complex relationship of these molecules, a first step is often examining the association
of microRNA expression with some other phenotypic variable(s). In our case, we consider a study
examining the relationship of occupational exposure benzene (a known carcinogen) to microRNA
expression. This study, like many of its kind, has a relative small sample size, but large ambitions
regarding the teasing out of associations of many thousands of potential microRNA’s. In this paper,
we propose a method that adaptively reduces the number of tests so that a study can preserve
reasonable power even when the number of potential tests is huge.
Speaking generally, current problems of statistical inference involving multiple hypothesis testing
share the following characteristics: inference for high- dimensional multivariate distributions, with
complex and unknown dependence structures among variables; a variety of parameters of interest,
such as coefficients in general regression models relating possibly censored biological and clinical
covariates and outcomes to genome-wide expression measures and genotypes; many null hypotheses,
in the thousands or even millions; complex and unknown dependence structures among test statistics.
An often-ignored yet insidious issue with small-sample inference and large numbers of comparisons
is the enormous sample sizes required for joint convergence, by the central limit theorem, of the joint
sampling distribution to a multivariate normal distribution. Unfortunately, others have shown that
for convergence to multivariate normal distribution in the far tails (to derive accurate adjustment
for multiple testing) requires astronomical sample sizes (e.g., from high-throughput sequencing tech-
nologies). Gerlovina and Hubbard (2016) employed Edgeworth expansions to rigorously study the
manner in which the number of tests performed affects the accuracy of the resultant analyses, with
particular attention paid to situations where the number of tests vastly outnumbers the sample size.
Here, the utility of Edgeworth series lies in their providing, by way of higher-order approximations,
estimates of critical values that would otherwise be computed exactly were the true distribution
known. In any case, these expansions and associated simulations of multiple testing experiments
showed that error control can be wildly anti-conservative if sample size is inadequate. Thus, using
standard and commonly used multiple testing techniques can make it practically impossible to obtain
honest statistical inference when conducting very large numbers of tests.
Motivated by the broad use of multiple testing procedures for very large numbers of tests, and
the limitations of existing multiple testing procedures, we present in this paper a technique for data-
adaptive multiple testing in high-dimensional problems, one that harnesses data mining procedures
2
to perform variable reduction, whilst preserving accurate and honest statistical inference. This new
method is a natural extension of the data-adaptive statistical target parameter framework introduced
by Hubbard and van der Laan (2016), who show that this new class of inference procedures provides
an impetus for using methods providing rigorous statistical inference for data-mining procedures.
The proposed approach for multiple testing in high-dimensional settings uses data-adaptive test
statistics, which rely on cross-validation, to perform variable reduction by screening algorithms. Typ-
ically, the method uncovers associations that represent signals that are stable across the full sample,
while allowing for multiple testing efforts to be restricted to a much smaller subset of biomarkers
(predictors). It is expected that this new class of test statistics outperforms, in terms of improve-
ments in both power and control of type-I error rate, standard test statistics generated by classical
approaches to multiple hypothesis testing, in which variable set is pre-specified.
In section 2, we proceed to define this methodology in generality with the aforementioned estima-
tion strategies, present theorems establishing its asymptotic statistical performance, present influence
function and bootstrap-based inference, and discuss the implications of these theoretical results. In
section 3, we demonstrate the relative performance by way of simulation studies; in section 4, we
apply the general approach for high-dimensional multiple testing using data-adaptive test statistics
to the analysis of data from miRNA assays; and then conclude (in section 5) with remarks on the
implications of this new methodology to future work in analyzing data from biomedical investigations.
3
2 Methodology
2.1 Notation and setup
The procedure is straightforward and involves cross-validation to keep separate the data used for
choosing which tests to perform and the data used for constructing the test statistics and generating p-
values. Define the observed data as Oi = (Wi, Ai, Yi) ∼ P0, i = 1, ..., n, which consist of n independent
and identically distributed random samples from the population distribution P0, with P0 known to be
an element of a statistical modelM. For each observation, Yi is the outcome of interest of dimension
p and can be a real number or class variable. Ai is a 1-dimensional vector of treatment variable and
Wi is a multi-dimensional vector of baseline covariates.
Consider V-fold cross-validation, where the learning set L is randomly divided into V mutually
exclusive and exhaustive sets, Lv, v = 1, ..., V , of as nearly equal size as possible. We will define
the parameter-generating sample for v, L − Lv, the sample used to select which of the original set
of hypotheses should be considered for future testing. Then, the estimates are computed on the
estimation-sample Lv, and averaged (details below) across the v. The proportion p of observations
in the estimation-sample Lv is approximately 1/V .
For a given random split v, let Pn,vc be the empirical distribution of the parameter-generating
sample L−Lv, and Pn,v be the empirical distribution of the estimation-sample Lv. Ψv,Pn,vc :M→ R
is the target parameter mapping indexed by the parameter-generating sample Pn,vc , and Ψ̂v,Pn,vc :
MNP → R the corresponding estimator of this target parameter. For instance, one might use an
algorithm within the training sample to subset variables based on, say, ranking by some statistic
(e.g., differential expression). Thus, Ψv,Pn,vc could be the mean difference between two groups of
this random subset of variables. Here, M is a nonparametric model and an estimator is defined
as an algorithmic mapping from a nonparametric model, including all of the constituent empirical
distributions, to the parameter space. For simplicity, assume that the parameter is real-valued. Thus,
the target parameter mapping and estimator can depend not only on the parameter-generating sample
Pn,vc , but also on the particular split v.
Assume the existence of a mapping from the parameter-generating sample Pn,vc into a target
parameter mapping and a corresponding estimator of that target parameter. The choice of target
parameter mapping and corresponding estimator can be informed by the data Pn,vc but not by the es-
timation sample Pn,v – that is, one only need know the realization of the mapping from the parameter-
generating sample to the space of target parameter mappings and estimators
(
Ψv,Pn,vc , Ψ̂v,Pn,vc
)
, but
not the explicit definition of said mapping.
Define the sample-split data-adaptive statistical target parameter as Ψn :M→ R with
Ψn (P ) = EvΨv,Pn,vc (P )
and the statistical estimand of interest is thus
Ψn,0 = Ψn (P0) = EvΨv,Pn,vc (P0) = Avev
Ψv,Pn,vc (P0) .
4
Note that this target parameter mapping depends on the data, which is the reason for calling it
a data-adaptive target parameter. A corresponding estimator of the data-adaptive estimand Ψn,0 is
given by:
Ψn = Ψ (Pn) = EvΨv,Pn,vc (Pn,v) .
2.2 Data-adaptive test statistics
In this section, we consider a rank-based approach to generate a test statistic on a reduced set of
responses S0 ⊂ Y , where S0 is a subset of the full observed data determined by the application of a
selection procedure on the parameter-generating sample. The data-adaptive statistic is identified by
three components: the cardinality of the reduced set denoted by p∗ , |S0|, the parameter-generating
algorithm, and the number of folds V in cross-validation.
Specifically, for each parameter-generating sample L−Lv, we simply rank by B̂j = EPn,vc (Yj|A = 1)−
EPn,vc (Yj|A = 0), which is the empirical average treatment effect of A on Yj. Within each fold v,
the parameter-generating algorithm returns the rank of each response covariate by its effect size B̂j
using the the parameter-generating sample L−Lv, and the set SPn,vc is defined by taking the top p∗
j’s ( we have arbitrarily chosen p∗ = 30).
The parameter of interest is the average treatment effect Ψn,j = EPn (Yj|A = 1)−EPn (Yj|A = 0),
estimated by Ψv,Pn,vc ,j (Pn,v) = EPn,v
(
YSPn,vc ,j
∣∣∣A = 1)−EPn,v (YSPn,vc ,j∣∣∣A = 0) using the estimation-
sample Lv. The efficient influence curve of Ψv,Pn,vc ,j is derived in van der Laan and Petersen (2012)
and can be represented as
D∗(P )(O) = H(g)(A,W )
(
Y −Q(A,W ))+Q(1,W )−Q(0,W )−Ψ(Q),
where Q(a,W ) = EP (Y |W,A = a), H(g)(A,W ) = (2A− 1)/g(A|W ), and g(A|W ) = EP (A = 1|W ).
We calculate the efficient influence curves D∗(Pn,vc)(O) also on the estimation-sample, which will be
useful when we later calculate test statistics.
We repeat the procedure for all V folds, and take the average EvΨv,Pn,vc,j (Pn,v) for each Yj that
are selected in any single fold SPn,vc , v = 1, . . . , V . The calculated efficient influence curves are
combined across all V folds and used to derive asymptotic distribution of target parameters and
perform statistical testing. The p-values for the Yj in the final reduced set can be constructed based
on asymptotic linearity of the TMLE (van der Laan and Petersen, 2012). Under regularity conditions
on the estimates of Q(A,W ) and g(A|W ),
√
n (ψn,Pn,j(Pn)− ψn,Pn,j(P0)) ∼ N
(
0, σEIC
2
)
,
where
σEIC,j
2 =
1
n
n∑
i=1
D∗j2(Oi)
is the empirical variance of efficient influence curve. As a result, the test statistics based on the re-
sponse matrix YS0 are computed using asymptotic normal distribution of each single target parameter,
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thus we have a p-value for each selected Yj in S
0. The false discovery rate of the corresponding test
p-values (p1, . . . , pp∗) can be controlled, for example, using the well-established Benjamini-Hochberg
procedure for controlling the False Discovery Rate (FDR) (Benjamini and Hochberg, 1995).
The data-adaptive parameter-generating procedure not only reduces the multiplicity of the hy-
pothesis tests compared with directly applying multiple testing methodologies, but it also generates
summary statistics that validate the robustness and credibility of the result. A plot of sorted Q-values
can become useful when a lot of covariates are significant. If the smallest Q-values are similar among
each other, and as a group much smaller than the rest (still significant) covariates, we can identify the
cluster of smallest Q-values to be of most scientific interest. In addition to looking at the Q-values,
which is a measure of statistical significance, practitioners can evaluate the scientific significance by
looking at the magnitude of average treatment effect. Percentage of each Yj to be selected in S
0
v
across all V folds can be viewed as a measure of association robustness. So is the average rank of
each covariate across V folds.
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3 Simulation
We consider a situation that has an analogue in high-dimensional data generated by microRNA
data discussed above. The method evaluated in this simulation study uses the parameter-generating
sample to select a small subset of the original genes, and subsequently it uses the estimation sample
to validate the effect of these genes on a phenotype of interest. In this manner, it avoids the need
to apply multiple testing procedures that control a Type-I error rate among a comparatively large
number of tests.
Let O = (A, Y = (Y1, Y2, . . . , Yp)) where A is a binary vector, and Y a multivariate outcome.
The true probability distribution, P0, is generated based on a design where there is equal probability
of A = 0 and A = 1; moreover, for each gene j, the distribution of Yj, given A, is defined by the
following regression equation:
Yj = B0,j +B1,jA+ ej, j = 1, . . . , p
The coefficient B0,j is generated by a standard normal distribution, and the coefficient B1,j takes
a fixed sparse design, with B1,1 = B1,2 = · · · = B1,10 = 1 and B1,11 = B1,12 = · · · = B1,p = 0. As a
result, we generated 10 true effects and (p− 10) null effects. Note, that these coefficients are fixed in
the simulation. The errors ej were independent draws from a random N (0, σ
2
e) distribution, and we
repeated the simulation not only for different magnitudes of the residual error (different realizations
of σ2e), but also for increasing sample sizes. We define our data-adaptive statistical target parameter
as outlined in 2.1, where we set the dimension of the reduced response matrix p∗ to be 15. Data on
a total of p = 106 potential biomarkers were generated.
Directly adjusting p-values using the method of Benjamini and Hochberg (1995), for controlling
the FDR, on all 106 responses yields the plot in 2. Note that 8 out of the top 10 true effects failed to
achieve significance despite a signal-to-noise ratio of 10, due to adjustment on too large a dimension.
Running the data-adaptive algorithm on the parameter-generating samples provides a reasonable
recovery of true effect responses. The results are given below:
From the table, it is clear that the approach of data-adaptive statistical target parameter estima-
tion consistently picks out the true effects in the top candidates. After application of the Benjamini
and Hochberg (1995) procedure on the reduced set of responses, 74 out of 10 true signals are still
significant.
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Figure 1: Plot of adjusted p-values using all response covariates
Table 1: Summary of the results of data-adaptive statistical target parameter estimation
covar. ID ATE est. p-value adjusted p-value mean CV-rank % times in top 15
1 6 1.3474 2.05E-10 3.07E-09 1.1 100
2 1 1.2498 1.35E-08 9.72E-08 2.4 100
3 4 1.2406 1.94E-08 9.72E-08 2.8 100
4 5 1.0822 1.08E-07 4.04E-07 4.8 100
5 10 1.0250 3.43E-07 8.58E-07 7.3 90
6 16109 0.9605 3.32E-07 8.58E-07 11.4 70
7 8 0.9793 1.12E-05 1.38E-05 11.5 70
8 9 0.9073 3.11E-06 5.18E-06 26.9 40
9 23969 0.9172 2.66E-05 2.66E-05 27 50
10 910425 0.9107 2.07E-06 4.43E-06 27.1 30
11 398395 0.8975 7.44E-06 1.01E-05 27.7 20
12 975142 0.9127 2.94E-06 5.18E-06 28.1 40
13 963171 0.9124 1.19E-05 1.38E-05 28.7 40
14 491156 0.9425 5.36E-06 8.04E-06 31.7 50
15 619251 0.8970 1.55E-05 1.66E-05 35.2 50
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Figure 2: Plot of adjusted p-values using data-adaptive test statistics
4 Differentially expressed microRNA and exposure to ben-
zene
Benzene, an established cause of acute myeloid leukemia (AML), may also cause one or more lymphoid
malignancies in humans. Previous studies have identified single nucleotide polymorphisms (SNP) and
patterns of DNA methylation associated with exposure to benzene through transcriptomic analyses
of blood cells from a small number of occupationally exposed workers (Zhang et al., 2010); however,
in these studies, the effect of benzene-induced changes to microRNA expression (Affymetrix 3.0
GeneChips which contain probes for 5639 human miRNAs) in blood cells was not the subject of
intense scrutiny. We discuss a study of 85 individuals in Tianjin, China, in which 56 workers exposed
to varying levels of benzene and 29 unexposed control counterparts were monitored repeatedly for up
to 12 months. For each individual, blood samples were collected and miRNA expression was measured
and log-transformed, leading to the formulation of a statistical problem in which a large number of
comparisons arises from performing miRNA screens on both exposed subjects and unexposed controls.
To illustrate the flexibility of the proposed method we will show how it can be used as a powerful
test for differentially expressed microRNA. The data consist of 5639 real-valued outcomes and one
binary treatment for 85 individuals. In univariate testing, the microRNA hsa-miR-320a st has the
smallest p-value (p < 0.000455). However the association is no longer significant after controlling for
multiple testing using the Benjamini-Hochberg (Benjamini and Hochberg, 1995) method to control
the False Discovery Rate (padjusted = 0.5281). Since our objective of interest was to detect the top
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differentially expressed microRNAs. (and not to differentiate all microRNAs), we generated data-
adaptive test statistics to reduce the number of hypotheses based on the procedure outlined in 2.1
Table 2: Top microRNA’s after direct applying Benjamini-Hochberg (Down-regulated)
microRNA ATE Fold Change p-value adjusted p-value
1 hsa-miR-744 st -0.35 0.79 0.00067 0.52814
2 hsa-miR-320b st -0.32 0.80 0.00046 0.52814
3 hsa-miR-320a st -0.31 0.80 0.00045 0.52814
4 hsa-miR-320c st -0.30 0.81 0.00082 0.52814
5 hp hsa-mir-449b x st -0.23 0.85 0.00084 0.52814
6 ENSG00000238375 st -0.20 0.87 0.00071 0.52814
7 hp hsa-mir-4645 st -0.18 0.88 0.00077 0.52814
Table 3: Top microRNA’s after direct applying Benjamini-Hochberg (Up-regulated)
microRNA ATE Fold Change p-value adjusted p-value
1 hsa-miR-338-5p st 0.83 1.78 0.00079 0.52814
2 hsa-miR-103a-2-star st 0.66 1.58 0.00061 0.52814
3 hsa-miR-4725-3p st 0.34 1.26 0.00094 0.53127
(a)
0 1000 2000 3000 4000 5000
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Unadjusted P-values
Index
p-
va
lue
(b)
0 1000 2000 3000 4000 5000
0.
6
0.
7
0.
8
0.
9
1.
0
Benjamini-Hochberg adjusted P-values
Index
p-
va
lue
Figure 3: Plot of (a) unadjusted and (b) FDR adjusted p-values using all covariates
Given the multiplicity of comparisons, we propose the use of data-adaptive test statistics to reduce
the number of comparisons first, thereby increasing power, while still maintaining accurate statistical
inference. We specified the reduced set of response matrix Ŷ with dimension n×30, which correspond
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to studying top 30 microRNAs that will express differently under benzene exposure. We carried out
10-fold cross-validation to calculate the data-adaptive test statistics and tested each of the top 30
microRNAs. We finally performed FDR correction ((Benjamini and Hochberg, 1995)) on the 30 raw
p-values.
4.1 Results
The results for the top 30 microRNAs and their FDR-adjusted p-values are shown in Table 4. 19 out
of 30 top microRNAs had a significant differential expression (q-value < 0.05) while we found none
in FDR-corrected t-tests in Table 2. Observing the plot of FDR-adjusted p-values (Figure 4) also
gives us insights as we can easily identify groups of significant p-values. In practice, we can choose a
cutoff based on the trend of sorted p-values. The average rank of the top covariates (in Table 4) can
also be referenced as a measure of stability of the effect across different subjects.
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Figure 4: Adjusted p-values using data-adaptive test statistics (Down-regulated)
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Table 4: Summary of the data-adaptive test statistics on miRNA data (Down-regulated)
microRNA ATE raw p-values adjusted p-values avg rank % appear in top 30
1 hsa-miR-134 st -0.87 0.0197 0.0492 2.4 100
2 hsa-miR-3613-3p st -0.86 0.0003 0.0089 2.7 100
3 hsa-miR-4668-5p st -0.77 0.0034 0.0144 4.5 100
4 hsa-miR-382 st -0.80 0.0294 0.0493 6.2 100
5 U49A s st -0.70 0.0019 0.0114 7.5 100
6 hsa-miR-409-3p st -0.75 0.0312 0.0493 8.1 100
7 hsa-miR-3651 st -0.67 0.0271 0.0493 8.7 100
8 hsa-miR-432 st -0.72 0.0657 0.0777 10.0 100
9 hp hsa-mir-548ai st -0.63 0.0169 0.0461 11.6 100
10 hsa-miR-1301 st -0.61 0.0008 0.0114 11.7 100
11 hsa-miR-1275 st -0.57 0.0015 0.0114 14.9 100
12 hsa-miR-200c st -0.57 0.0016 0.0114 16.2 90
13 ENSG00000199411 s st -0.56 0.0438 0.0597 16.7 80
14 hp hsa-mir-548ai x st -0.52 0.0229 0.0493 22.8 80
15 hsa-miR-423-5p st -0.50 0.0023 0.0117 23.6 80
16 U56 st -0.51 0.0503 0.0656 24.5 80
17 ENSG00000252921 x st -0.49 0.0048 0.0180 26.9 70
18 U49B s st -0.49 0.0112 0.0335 27.3 80
19 U38A st -0.49 0.0749 0.0833 28.4 70
20 hsa-miR-3613-5p st -0.51 0.2265 0.2343 30.5 70
21 hsa-miR-99b st -0.47 0.0674 0.0777 33.8 50
22 hsa-miR-486-5p st -0.46 0.0054 0.0181 34.5 70
23 hsa-miR-339-3p st -0.45 0.0245 0.0493 37.3 40
24 U49A st -0.43 0.0309 0.0493 39.7 30
25 HBII-85-2 x st -0.43 0.0247 0.0493 39.9 20
26 U21 st -0.44 0.0391 0.0559 39.9 40
27 hsa-miR-4529-3p st -0.49 0.2706 0.2706 42.0 50
28 hsa-miR-940 st -0.44 0.0340 0.0510 42.2 50
29 hsa-miR-584 st -0.45 0.0796 0.0853 42.3 50
30 hsa-miR-150-star st -0.43 0.0524 0.0656 43.6 20
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Table 5: List of microRNA’s that are still significant after FDR correction (Down-regulated)
microRNA
1 hsa-miR-134 st
2 hsa-miR-3613-3p st
3 hsa-miR-4668-5p st
4 hsa-miR-382 st
5 U49A s st
6 hsa-miR-409-3p st
7 hsa-miR-3651 st
8 hp hsa-mir-548ai st
9 hsa-miR-1301 st
10 hsa-miR-1275 st
11 hsa-miR-200c st
12 hp hsa-mir-548ai x st
13 hsa-miR-423-5p st
14 ENSG00000252921 x st
15 U49B s st
16 hsa-miR-486-5p st
17 hsa-miR-339-3p st
18 U49A st
19 HBII-85-2 x st
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The same analysis can be performed on up-regulated microRNA’s. 20 out of 30 top microRNAs
had a significant differential expression (q-value < 0.05) as did the hsa-miR-338-5p st and hsa-miR-
103a-2-star st that we found in FDR-corrected t-tests in Table 3.
Table 6: Summary of the data-adaptive test statistics on miRNA data (Up-regulated)
microRNA ATE raw p-value adjusted p-value avg rank % appear in top 30
1 hsa-miR-505 st 1.0175 0.001144 0.006465 1.2 100
2 hsa-miR-4772-3p st 0.8763 0.001508 0.006465 3.4 100
3 hsa-miR-10a st 0.8983 0.000979 0.006465 3.8 100
4 hsa-miR-338-5p st 0.8313 0.000155 0.002986 5.3 100
5 hsa-miR-301a st 0.8373 0.011351 0.026194 5.4 100
6 hsa-miR-212 st 0.8158 0.001421 0.006465 6.1 100
7 hsa-miR-374b st 0.7728 0.035704 0.051006 7.6 100
8 hsa-miR-454 st 0.776 0.012762 0.02691 7.9 100
9 hsa-miR-7-1-star st 0.7271 0.013911 0.02691 10.1 100
10 hsa-miR-4674 st 0.727 0.047842 0.064645 12.4 90
11 hsa-miR-30b st 0.6837 0.094063 0.104514 14.3 100
12 hsa-miR-29c-star st 0.6499 0.002409 0.009034 15.5 100
13 hsa-miR-103a-2-star st 0.6597 0.000199 0.002986 15.8 100
14 hsa-let-7d-star st 0.6519 0.014352 0.02691 16.4 100
15 hsa-miR-142-5p st 0.6668 0.049561 0.064645 17.7 90
16 hsa-miR-361-3p st 0.6136 0.02849 0.043226 20.5 90
17 hsa-miR-1231 st 0.6032 0.005194 0.01501 21.1 90
18 hsa-miR-99a st 0.6099 0.119402 0.123519 22.4 80
19 hsa-miR-589-star st 0.5867 0.018542 0.032722 23 80
20 hsa-miR-3188 st 0.581 0.001158 0.006465 24.3 80
21 hsa-miR-3621 st 0.5967 0.091534 0.104514 25 70
22 hsa-let-7g st 0.5883 0.212763 0.212763 29.3 70
23 hsa-miR-148a st 0.5586 0.113839 0.12197 29.3 60
24 hsa-miR-378g st 0.537 0.021924 0.036541 32.1 40
25 hsa-miR-30e-star st 0.5392 0.082371 0.098846 32.6 40
26 hsa-miR-641 st 0.531 0.005503 0.01501 33.3 30
27 hsa-miR-221-star st 0.546 0.028817 0.043226 33.6 60
28 hsa-miR-181a-star st 0.5398 0.057202 0.071502 34.1 60
29 hsa-miR-186 st 0.5304 0.009065 0.02266 34.5 30
30 hsa-miR-3187-3p st 0.524 0.005102 0.01501 35.7 30
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Table 7: List of microRNA’s that are still significant after FDR correction (Up-regulated)
microRNA
1 hsa-miR-505 st
2 hsa-miR-4772-3p st
3 hsa-miR-10a st
4 hsa-miR-338-5p st
5 hsa-miR-301a st
6 hsa-miR-212 st
7 hsa-miR-454 st
8 hsa-miR-7-1-star st
9 hsa-miR-29c-star st
10 hsa-miR-103a-2-star st
11 hsa-let-7d-star st
12 hsa-miR-361-3p st
13 hsa-miR-1231 st
14 hsa-miR-589-star st
15 hsa-miR-3188 st
16 hsa-miR-378g st
17 hsa-miR-641 st
18 hsa-miR-221-star st
19 hsa-miR-186 st
20 hsa-miR-3187-3p st
15
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Figure 5: Adjusted p-values using data-adaptive test statistics (Up-regulated)
Overall, this formally confirms the conclusions in the paper that by generating the data-adaptive
test statistics we can increase the power of testing a large set of statistical hypotheses and at the
same time control the level of false positive rate (or false discovery rate).
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5 Discussion
The goal of this article is to introduce a generalized class of robust procedures for performing sta-
tistical tests in high-dimensional settings, relying on the approach of data-adaptive statistical target
parameters. Here, we have introduced, in generality, the theory and methodology underlying the
use of data-adaptive statistics for multiple testing, illustrating key advantages of this approach via
simulation studies and providing examples where relevant. By providing the theoretical formalisms
in a generalized way, we have exposed a flexible framework in which the number of multiple testing
corrections applied in high-dimensional problems can be reduced, allowing for signals that would
otherwise be made undetectable by said corrections to be recovered.
In the example provided, we demonstrate the power of the approach based on data-adaptive
test statistics in the context of a study of miRNA. We show that this new class of approaches
for analyzing high-dimensional data sets allows researchers to derive improved statistical power in
problems plagued by multiple testing, by allowing for relatively fewer null hypotheses of interest to be
generated data-adaptively – that is, suggested by the observed data. In order to improve accessibilty
to the methodology presented herein, Cai et al. (2017) have developed and made publicly available
an open-source software package for data-adaptive multiple testing, available for the R statistical
computing language (R Core Team (2016)).
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